{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T18:47:21Z","timestamp":1789238841426,"version":"build-2803163510"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2023,7,20]],"date-time":"2023-07-20T00:00:00Z","timestamp":1689811200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,7,20]],"date-time":"2023-07-20T00:00:00Z","timestamp":1689811200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100011912","name":"Taipei Veterans General Hospital","doi-asserted-by":"publisher","award":["V107E-007-1 (108)"],"award-info":[{"award-number":["V107E-007-1 (108)"]}],"id":[{"id":"10.13039\/501100011912","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011912","name":"Taipei Veterans General Hospital","doi-asserted-by":"publisher","award":["V108E-007-1 (108)"],"award-info":[{"award-number":["V108E-007-1 (108)"]}],"id":[{"id":"10.13039\/501100011912","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011912","name":"Taipei Veterans General Hospital","doi-asserted-by":"publisher","award":["V108E-007-1 (109)"],"award-info":[{"award-number":["V108E-007-1 (109)"]}],"id":[{"id":"10.13039\/501100011912","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011912","name":"Taipei Veterans General Hospital","doi-asserted-by":"publisher","award":["V110E-002-1"],"award-info":[{"award-number":["V110E-002-1"]}],"id":[{"id":"10.13039\/501100011912","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Clin Microbiol Infect Dis"],"published-print":{"date-parts":[[2023,9]]},"DOI":"10.1007\/s10096-023-04644-3","type":"journal-article","created":{"date-parts":[[2023,7,20]],"date-time":"2023-07-20T18:03:33Z","timestamp":1689876213000},"page":"1103-1113","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["High carriage rate of extended\u2010spectrum \u03b2\u2010lactamase Enterobacterales and diarrheagenic Escherichia coli in healthy donor screening for fecal microbiota transplantation"],"prefix":"10.1007","volume":"42","author":[{"given":"Chien","family":"Chuang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kuei-Chuan","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yen-Po","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pei-Chang","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tien-En","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi-Hsiang","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4466-8486","authenticated-orcid":false,"given":"Yi-Tsung","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming-Chih","family":"Hou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,7,20]]},"reference":[{"key":"4644_CR1","doi-asserted-by":"publisher","first-page":"1324","DOI":"10.1053\/j.gastro.2018.12.019","volume":"156","author":"CL Hvas","year":"2019","unstructured":"Hvas CL, Dahl J\u00f8rgensen SM, J\u00f8rgensen SP et al (2019) Fecal microbiota transplantation is superior to fidaxomicin for treatment of recurrent Clostridium difficile infection. Gastroenterology 156:1324\u201332.e3","journal-title":"Gastroenterology"},{"issue":"Suppl 2","key":"4644_CR2","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1016\/j.cmi.2021.09.038","volume":"27","author":"J van Prehn","year":"2021","unstructured":"van Prehn J, Reigadas E, Vogelzang EH et al (2021) European Society of Clinical Microbiology and Infectious Diseases: 2021 update on the treatment guidance document for Clostridioides difficile infection in adults. Clin Microbiol Infect 27(Suppl 2):S1\u2013S21","journal-title":"Clin Microbiol Infect."},{"issue":"12","key":"4644_CR3","doi-asserted-by":"publisher","first-page":"1044","DOI":"10.1016\/j.cgh.2011.08.014","volume":"9","author":"JS Bakken","year":"2011","unstructured":"Bakken JS, Borody T, Brandt LJ et al (2011) Treating Clostridium difficile infection with fecal microbiota transplantation. Clin Gastroenterol Hepatol 9(12):1044\u20139","journal-title":"Clin Gastroenterol Hepatol."},{"key":"4644_CR4","doi-asserted-by":"publisher","first-page":"2043","DOI":"10.1056\/NEJMoa1910437","volume":"381","author":"Z DeFilipp","year":"2019","unstructured":"DeFilipp Z, Bloom PP, Torres Soto M et al (2019) Drug-resistant E. coli bacteremia transmitted by fecal microbiota transplant. N Engl J Med 381:2043\u20132050","journal-title":"N Engl J Med"},{"key":"4644_CR5","doi-asserted-by":"publisher","first-page":"e876","DOI":"10.1093\/cid\/ciaa1486","volume":"72","author":"C Zellmer","year":"2021","unstructured":"Zellmer C, Sater MRA, Huntley MH et al (2021) Shiga toxin-producing E. coli transmission via fecal microbiota transplant. Clin Infect Dis 72:e876\u2013e880","journal-title":"Clin Infect Dis"},{"key":"4644_CR6","unstructured":"OpenBiome. OpenBiome announces enhanced donor screening protocols following FDA alert. March 13, 2020. https:\/\/www.openbiome.org\/press-releases\/2020\/3\/12\/openbiome-announces-enhanced-donor-screening-protocols-following-fda-alert. Accessed 7 December 2022"},{"key":"4644_CR7","unstructured":"US Food and Drug Administration. Important safety alert regarding use of fecal microbiota for transplantation and risk of serious adverse reactions due to transmission of multi-drug resistant organisms. June 13, 2019. https:\/\/www.fda.gov\/vaccines-blood-biologics\/safety-availability-biologics\/important-safety-alert-regarding-use-fecal-microbiota-transplantation-and-risk-serious-adverse. Accessed 7 December 2022"},{"key":"4644_CR8","unstructured":"US Food and Drug Administration. Information pertaining to additional safety protections regarding use of fecal microbiota for transplantation - testing of stool donors for enteropathogenic Escherichia coli and Shigatoxin-producing Escherichia coli. April 6, 2020. https:\/\/www.fda.gov\/vaccines-blood-biologics\/safety-availability-biologics\/information-pertaining-additional-safety-protections-regarding-use-fecal-microbiota-transplantation-0. Accessed 7 December 2022"},{"key":"4644_CR9","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1016\/j.jmii.2019.08.009","volume":"52","author":"TC Lin","year":"2019","unstructured":"Lin TC, Hung YP, Ko WC et al (2019) Fecal microbiota transplantation for Clostridium difficile infection in Taiwan: establishment and implementation. J Microbiol Immunol Infect 52:841\u201350","journal-title":"J Microbiol Immunol Infect"},{"key":"4644_CR10","doi-asserted-by":"publisher","first-page":"1002","DOI":"10.1128\/JCM.02327-16","volume":"55","author":"MH Woodworth","year":"2017","unstructured":"Woodworth MH, Neish EM, Miller NS et al (2017) Laboratory testing of donors and stool samples for fecal microbiota transplantation for recurrent Clostridium difficile infection. J Clin Microbiol 55:1002\u201310","journal-title":"J Clin Microbiol"},{"key":"4644_CR11","doi-asserted-by":"publisher","first-page":"1428","DOI":"10.1016\/j.dld.2021.04.009","volume":"53","author":"G Ianiro","year":"2021","unstructured":"Ianiro G, Porcari S, Bibb\u00f2 S et al (2021) Donor program for fecal microbiota transplantation: a 3-year experience of a large-volume Italian stool bank. Dig Liver Dis 53:1428\u201332","journal-title":"Dig Liver Dis"},{"key":"4644_CR12","unstructured":"Clinical and Laboratory Standards Institute (2021) M100-S31. Performance standards for antimicrobial susceptibility testing: 31th informational supplement. CLSI, Wayne, PA"},{"key":"4644_CR13","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1099\/jmm.0.050492-0","volume":"62","author":"L Ma","year":"2013","unstructured":"Ma L, Lu PL, Siu LK et al (2013) Molecular typing and resistance mechanisms of imipenem-non-susceptible Klebsiella pneumoniae in Taiwan: results from the Taiwan surveillance of antibiotic resistance (TSAR) study, 2002\u20132009. J Med Microbiol 62:101\u20137","journal-title":"J Med Microbiol"},{"key":"4644_CR14","doi-asserted-by":"publisher","first-page":"1889","DOI":"10.1128\/AEM.03222-15","volume":"82","author":"PA Chen","year":"2016","unstructured":"Chen PA, Hung CH, Huang PC et al (2016) Characteristics of CTX-M extended-spectrum \u03b2-lactamase-producing Escherichia coli strains isolated from multiple rivers in southern Taiwan. Appl Environ Microbiol 82:1889\u201397","journal-title":"Appl Environ Microbiol"},{"key":"4644_CR15","doi-asserted-by":"publisher","first-page":"4178","DOI":"10.1128\/JCM.43.8.4178-4182.2005","volume":"43","author":"L Diancourt","year":"2005","unstructured":"Diancourt L, Passet V, Verhoef J et al (2005) Multilocus sequence typing of Klebsiella pneumoniae nosocomial isolates. J Clin Microbiol 43:4178\u201382","journal-title":"J Clin Microbiol"},{"key":"4644_CR16","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1086\/313770","volume":"30","author":"B Svenungsson","year":"2000","unstructured":"Svenungsson B, Lagergren A, Ekwall E et al (2000) Enteropathogens in adult patients with diarrhea and healthy control subjects: a 1-year prospective study in a Swedish clinic for infectious diseases. Clin Infect Dis 30:770\u20138","journal-title":"Clin Infect Dis"},{"key":"4644_CR17","doi-asserted-by":"publisher","first-page":"ofx243","DOI":"10.1093\/ofid\/ofx243","volume":"4","author":"LJ Craven","year":"2017","unstructured":"Craven LJ, Nair Parvathy S, Tat-Ko J et al (2017) Extended screening costs associated with selecting donors for fecal microbiota transplantation for treatment of metabolic syndrome-associated diseases. Open Forum Infect Dis 4:ofx243","journal-title":"Open Forum Infect Dis"},{"key":"4644_CR18","doi-asserted-by":"publisher","first-page":"2070","DOI":"10.1056\/NEJMc1913670","volume":"381","author":"Z Kassam","year":"2019","unstructured":"Kassam Z, Dubois N, Ramakrishna B et al (2019) Donor screening for fecal microbiota transplantation. N Engl J Med 381:2070\u20132","journal-title":"N Engl J Med"},{"key":"4644_CR19","doi-asserted-by":"publisher","first-page":"1236","DOI":"10.1177\/2050640620957765","volume":"8","author":"EM Terveer","year":"2020","unstructured":"Terveer EM, Vendrik KE, Ooijevaar RE et al (2020) Faecal microbiota transplantation for Clostridioides difficile infection: four years\u2019 experience of the Netherlands Donor Feces Bank. United Eur Gastroenterol J 8:1236\u20131247","journal-title":"United Eur Gastroenterol J"},{"key":"4644_CR20","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1056\/NEJMoa1205037","volume":"368","author":"E van Nood","year":"2013","unstructured":"van Nood E, Vrieze A, Nieuwdorp M et al (2013) Duodenal infusion of donor feces for recurrent Clostridium difficile. N Engl J Med 368:407\u201315","journal-title":"N Engl J Med"},{"key":"4644_CR21","doi-asserted-by":"publisher","first-page":"1600","DOI":"10.1097\/MIB.0000000000000405","volume":"21","author":"S Paramsothy","year":"2015","unstructured":"Paramsothy S, Borody TJ, Lin E et al (2015) Donor recruitment for fecal microbiota transplantation. Inflamm Bowel Dis 21:1600\u20136","journal-title":"Inflamm Bowel Dis"},{"key":"4644_CR22","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1093\/cid\/civ994","volume":"62","author":"SP Costello","year":"2016","unstructured":"Costello SP, Tucker EC, La Brooy J et al (2016) Establishing a fecal microbiota transplant service for the treatment of Clostridium difficile infection. Clin Infect Dis 62:908\u201314","journal-title":"Clin Infect Dis"},{"key":"4644_CR23","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1016\/j.cmi.2017.05.015","volume":"23","author":"EM Terveer","year":"2017","unstructured":"Terveer EM, van Beurden YH, Goorhuis A et al (2017) How to: establish and run a stool bank. Clin Microbiol Infect 23:924\u201330","journal-title":"Clin Microbiol Infect"},{"key":"4644_CR24","doi-asserted-by":"publisher","first-page":"966","DOI":"10.1053\/j.gastro.2021.11.004","volume":"162","author":"S Zhang","year":"2022","unstructured":"Zhang S, Chen Q, Kelly CR et al (2022) Donor screening for fecal microbiota transplantation in China: evaluation of 8483 candidates. Gastroenterology 162:966-968.e3","journal-title":"Gastroenterology"},{"key":"4644_CR25","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.1002\/ueg2.12160","volume":"9","author":"YK Yau","year":"2021","unstructured":"Yau YK, Mak WYJ, Lui NSR et al (2021) High prevalence of extended-spectrum beta-lactamase organisms and the COVID-19 pandemic impact on donor recruitment for fecal microbiota transplantation in Hong Kong. United Eur Gastroenterol J 9:1027\u201338","journal-title":"United Eur Gastroenterol J"},{"key":"4644_CR26","doi-asserted-by":"publisher","first-page":"424","DOI":"10.3343\/alm.2021.41.4.424","volume":"41","author":"HS Seo","year":"2021","unstructured":"Seo HS, Chin HS, Kim YH et al (2021) Laboratory aspects of donor screening for fecal microbiota transplantation at a Korean fecal microbiota bank. Ann Lab Med 41:424\u20138","journal-title":"Ann Lab Med"},{"key":"4644_CR27","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1016\/S1473-3099(20)30473-4","volume":"21","author":"KEW Vendrik","year":"2021","unstructured":"Vendrik KEW, Terveer EM, Kuijper EJ et al (2021) Periodic screening of donor faeces with a quarantine period to prevent transmission of multidrug-resistant organisms during faecal microbiota transplantation: a retrospective cohort study. Lancet Infect Dis 21:711\u201321","journal-title":"Lancet Infect Dis"},{"key":"4644_CR28","doi-asserted-by":"publisher","first-page":"dlac048","DOI":"10.1093\/jacamr\/dlac048","volume":"4","author":"YM Bezabih","year":"2022","unstructured":"Bezabih YM, Bezabih A, Dion M et al (2022) Comparison of the global prevalence and trend of human intestinal carriage of ESBL-producing Escherichia coli between healthcare and community settings: a systematic review and meta-analysis. JAC Antimicrob Resist 4:dlac048","journal-title":"JAC Antimicrob Resist"},{"key":"4644_CR29","doi-asserted-by":"publisher","first-page":"1402","DOI":"10.3389\/fmicb.2020.01402","volume":"11","author":"YS Huang","year":"2020","unstructured":"Huang YS, Lai LC, Chen YA et al (2020) Colonization with multidrug-resistant organisms among healthy adults in the community setting: prevalence, risk factors, and composition of gut microbiome. Front Microbiol 11:1402","journal-title":"Front Microbiol"},{"key":"4644_CR30","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1128\/AAC.05753-11","volume":"56","author":"HC Chung","year":"2012","unstructured":"Chung HC, Lai CH, Lin JN et al (2012) Bacteremia caused by extended-spectrum-\u03b2-lactamase-producing Escherichia coli sequence type ST131 and non-ST131 clones: comparison of demographic data, clinical features, and mortality. Antimicrob Agents Chemother 56:618\u201322","journal-title":"Antimicrob Agents Chemother"},{"key":"4644_CR31","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1016\/j.jmii.2017.08.005","volume":"51","author":"WL Tsai","year":"2018","unstructured":"Tsai WL, Hung CH, Chen HA et al (2018) Extended-spectrum \u03b2-lactamase-producing Escherichia coli bacteremia: comparison of pediatric and adult populations. J Microbiol Immunol Infect 51:723\u201331","journal-title":"J Microbiol Immunol Infect"},{"key":"4644_CR32","unstructured":"US Food and Drug Administration. Information pertaining to additional safety protections regarding use of fecal microbiota for transplantation \u2013 screening and testing of stool donors for multi-drug resistant organisms. June 18, 2019. https:\/\/www.fda.gov\/vaccines-blood-biologics\/safety-availability-biologics\/information-pertaining-additional-safety-protections-regarding-use-fecal-microbiota-transplantation. Accessed 7 December 2022"},{"key":"4644_CR33","doi-asserted-by":"publisher","first-page":"82.e1","DOI":"10.1016\/j.cmi.2017.05.010","volume":"24","author":"BK Decker","year":"2018","unstructured":"Decker BK, Lau AF, Dekker JP et al (2018) Healthcare personnel intestinal colonization with multidrug-resistant organisms. Clin Microbiol Infect 24:82.e1-82.e4","journal-title":"Clin Microbiol Infect"},{"issue":"3","key":"4644_CR34","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1007\/s10096-023-04548-2","volume":"42","author":"EI Campos-Madueno","year":"2023","unstructured":"Campos-Madueno EI, Moradi M, Eddoubaji Y et al (2023) Intestinal colonization with multidrug-resistant Enterobacterales: screening, epidemiology, clinical impact, and strategies to decolonize carriers. Eur J Clin Microbiol Infect Dis 42(3):229\u2013254","journal-title":"Eur J Clin Microbiol Infect Dis."}],"container-title":["European Journal of Clinical Microbiology & Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10096-023-04644-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10096-023-04644-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10096-023-04644-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,15]],"date-time":"2023-08-15T09:13:30Z","timestamp":1692090810000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10096-023-04644-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,20]]},"references-count":34,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2023,9]]}},"alternative-id":["4644"],"URL":"https:\/\/doi.org\/10.1007\/s10096-023-04644-3","relation":{},"ISSN":["0934-9723","1435-4373"],"issn-type":[{"value":"0934-9723","type":"print"},{"value":"1435-4373","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,7,20]]},"assertion":[{"value":"24 April 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 July 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 July 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the Institution Review Board of Taipei Veterans General Hospital. All subjects that participated in this study gave a written informed consent.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclaimer"}}]}}